DIABETES - BLINDNESS -

I'm sixty-seven years old and have Type II diabetes. I suffer from neuropathy and had difficulty sleeping at night because of the pain.
I have also had problems keeping my blood sugar stable. I tried to keep it down with prescription medication, but my blood sugar levels would climb as high as 325.

My blood pressure was over 200 and my kidneys tested at number 9, when they should be 1.5 or 1.8 my doctor thought I might end up on dialysis. Also, I've been blind for the past six years. The doctors say that my optic nerves are dead, they think that the chemicals I used while crop spraying my farm caused my blindness.

I felt hopeless until I heard about stem cell nutrition.

After taking it for sixty days, I went back to the doctor. My test results were unbelievable! My blood pressure had fallen to 110/70, and my blood sugar was a normal 90. The count on my kidneys had dropped from 9 to 4.5. Now I'm off all of my medication, and today my blood sugar is normal and stable.

My neuropathy is 75 percent improved. Because of my blindness, I had to use a large pencil to jot a few words on paper and now I use a small one instead. I can even see the red indicator light on my machine for the first time.

My doctor wrote to tell me that my hemoglobin test (for diabetic control) had the best results I've ever had. It was almost at our target of under 6.5. He said I was doing really well and to keep up the good work.

Because of stem cell nutrition, I now have hope of being able to drive and fly again and see the bobber when the fish bite!

I feel really good!.

Bill Lohmeyer.
Minnesota, USA.

These TESTIMONIALS are from Christian Drapeau, a member of Gitte Jensen, Ph.D, research team that creatod the patented Stem Enhance ULTRA.
These are actual testimonials as a result of testing the product on people with a variety of medical conditions.

Christian Drapeau holds an Honors Bachelor´s degree in Neurophysiology and a Master´s degree in Neurology and Neurosurgery, Stemcell Scientist, Botanical Researcher and Author.

My favourite testimonial is the 6th one below, RENAL FAILURE. A baby with Renal failure and the remarkable recovery in such a short time.
I read this testimonial to a Naturopath who told me that she had a friend whose baby had the exact same problem. BUT, the outcome there was that the baby had the kidney removed!!!!! Hello!!!

This is what inspires me to tell the World!
(HOW would you feel if this was your child?)


CLINICAL APPLICATION - SE = Stem Enhance

Investigation of the clinical potential of ESCM has been limited, largely due to the significant risk associated with the use of G-CSF, the main stem cell mobilizer used in clinical trial, for extended periods of time (Bensinger et al., 1996; Shimoda et al., 1993).
Recently, a new stem cell mobilizer (StemEnhance® SE) has been developed that triggers a much milder increase in the number of PBSC, but its safety allows for a sustained oral daily consumption over long periods of time, allowing for safe daily ESCM (Jensen et al., 2007).

In brief, SE is an extract from the cyanophyta Aphanizomenon flos-aquae that concentrates a protein with an estimated molecular weight of 160-180 kDa, which was shown to be a selective L-selectin blocker.
Oral consumption of 1 gram of SE was been shown to trigger an average 25% increase in the number of PBSC within 60 minutes after consumption. The magnitude of the mobilization induced by SE is much smaller than that triggered by G-CSF, however its safety allows for continuous use and therefore offers a novel approach in the study of ESCM.

To test its therapeutic potential, SE was used in a number of preliminary clinical trials involving a number of diagnostic entities.


PARKINSON - SE = Stem Enhance

MC is a 62 year old male with a 17 year history of Parkinson's Disease. MC was initially diagnosed with Parkinson's type resting pill-rolling tremor affecting his left hand and then progressing to the limbs on left side of his body. Over the course of five years the tremors increased gradually affecting the right side as well. At ten years into the disease process, MC was no longer able to practice as an attorney, mobility was affected and limitations increased compromising his personal and professional abilities.

In 2009, before the treatment of SE, the left side tremors had significantly worsened, symptoms of stiffness and bradykinesia which introduced a shuffling gait and poor balance made it unsafe for HM to ambulate without the use of a cane. At the time MC began consuming SE he was unable to dress himself, put on his watch, write, feed himself or drive his car.

After 45 days on the product, consuming 1 gram of SE, three times per day, MC showed significant improvement with decreased tremors, less stiffening and bradykinesia; at this time MC was able to get around without the use of his cane.

After 60 days on the product, judging that the benefits had plateaued, MC discontinued the use of SE.
Forty - five days later, signs of tremor and bradykinesia returned and MC was seeking medical attention, once again.

MC resumed SE with a dose of 2 grams, three times per day and within six weeks showed much improvement with less tremors, stiffness and bradykinesia. MC was able to participate in activities of daily living, such as dressing and feeding himself, he was also able to tie his own tie, put on his watch, and once again, he could ambulate without using a cane. To date MC has been on SE for two years, he has returned to driving his car without limitations, he is independent with all activities of daily living and he also participates in some level of professional activity.


Another patient, MT, is a 52 year old woman with an early onset of Parkinson at age 36, with tremor as the primary symptom. Early treatment consisted of Pergolid, then Budipin up to 30 mg three times a day. However due to QTc increase, Budipin was later reduced to 10 mg three times a day. The patient was also treated with Methydopamin 62.5 mg four times a day. With this treatment, MT's main problem was the experience of fluctuations and Tissue Regeneration - From Basic Biology to Clinical Application 184 the beginning of ON-OFF syndrome.

One year ago MT began consuming StemEnhance 1gram three times a day. Today MT's experiences only minor tremor accompanied with some dyskinetic syndrome and sometimes propulsion. Her quality of life has increased and she is much more socially active.


TRAUMATIC SPINAL CORD INJURY - SE = Stem Enhance

A preliminary trial with 8 individuals with spinal cord injuries was performed in a community centre in Hawaii. The cases all involved paraplegia and various degrees of quadriplegia. Of the 8 cases, 4 dropped due to various circumstances unrelated to the consumption of SE. Of the 4 remaining participants, 2 had repetitive periods of hospitalization that made their consumption of SE irregular. Of the two remaining participants, one experienced mild though significant improvement in mobility while the other participant experienced significant improvements in mobility.

The latter participant, VS, had a serious car accident 17 years prior to SE consumption and was left with traumatic brain injury that affected her speech and a significant spinal cord lesion. At the beginning of the trial, VS was able to lift her right leg approximately 15 centimetre from her chair with no lateral movement, and showed a total absence of movement in her left leg. She could move her arms, hands and fingers though the movements were very slow with little dexterity and precision. She had some ability to move in her bed but was unable to turn herself without assistance.
No data was available to document peripheral sensory perception of the lower limbs or nerve conductivity.

After 6 months of daily consumption of 3 grams of SE three times a day, VS could lift her right leg more than 30 centimetres from her chair, with lateral movement outside of her chair.

She could also lift her left leg off the chair and laterally outside of the chair. VS had less control over the movement of her left leg, though the magnitude of the movements was comparable to the movements seen with the right leg. After 10 months, VS was able to rotate herself in her bed unassisted and from a supine position she could lift both legs to a 90 degree angle and sit in her bed unassisted. Over the period of the trial her upper limbs also improved in dexterity and her speech showed mild though significant improvement.

VS comes from a disadvantage socio-economic environment and did not have access to physical therapy beyond the first few years of her injury, she therefore developed leg and feet deformities that prevented her from bearing weight and possibly resuming physical therapy.


CORONARY ARTERY DISEASE - SE = Stem Enhance

JP is a 60 year old South African male who experienced a heart attack at 51 years of age. After diagnosis of Coronary Artery Disease was made a stent placement was performed. Dietary and lifestyle changes were implemented immediately by JP following the hospitalization. Unfortunately, 3 years later, JP suffered four additional heart attacks.

During the hospitalization, the angiogram revealed the right and left coronary arteries were obstructed 100% and 40%, respectively, thus determining that JP was not a good candidate for bypass surgery. At the time of the last hospitalization, JP had decreased energy and experienced "stable" angina with any exertion, and his overall quality of life was greatly compromised. JP was put on a medication regimen which consisted of Atenolol 50mg daily, The Therapeutic Potential of Stimulating Endogenous Stem Cell Mobilization 185 Perindopril 4 mg daily, Elantan 20 mg twice per day, Simvostatin 20 mg daily, Adelat xl 30mg daily, and Aspirin 1 per day.

JP was then put on a list for possible heart transplant.

Three weeks after discharge JP began consuming SE (Stem Enhance), 1 gram three times per day.

After 3 months of taking the product, he received a call for a possible heart transplant and returned to see his cardiologist for evaluation and comprehensive testing. The cardiologist reported that JP was making a remarkable recovery, the heart transplant surgery was postponed.

Four months later JP was re-evaluated and found to have made a complete recovery. JP has since been returning at 6 month intervals for follow up evaluation, and to date he has been stable with no further coronary incidents. The evaluations and most recent ECG conclude that JP has normal heart function.

Presently, JP shares that he is not on any medications, blood pressure is 126/65 mm Hg, he continues to take SE and experiences good quality of life.


DIABETES and RHEUMATOID ARTHRITIS - SE = Stem Enhance

NA is a 47 year old Colombian woman who was diagnosed at 18 year of age with deforming rheumatoid arthritis. Over the years she managed her condition with the use of Prednisone, Methotrexate, Sulfasalazina, and Diclofenac. Four years ago NA was diagnosed with diabetes mellitus with glycemia reaching 308 mg/dL and assumed treatment with Euglucon 5 mg twice a day along with NPH insulin.

About one year ago, due to her arthritic condition she became wheelchair bound and required assistance for bathing and dressing. At that time her medical records show levels of C-Reactive Protein (CRP) of 96.2 mg/L, Erythrocytes sedimentation rate (ESR) of 81 mm/H, Platelet count of 535 K/ul, fasting glucose of 147mg/dL and HgbA1c (or Glycosylated Haemoglobin) of 8.07.

A few months after becoming wheelchair bound NA began consuming 1 gram of SE once a day. After one month she subjectively reported a reduction in pain and inflammation, while 3 months later her mobility had improved to the point that she could bathe and dress alone.

After 6 months she began using a walker, then switched to a cane and one year later she was walking unaided.

Her last medical records indicate a level of CRP of 2.1 mg/L, ESR of 34 mm/H, Platelet count of 485 K/ul. NA has also discontinued the use of any diabetes medication; her records indicate a fasting glucose of 106 mg/dL with a glycaemia not exceeding 120 mg/dL and HgbA1c of 5.62.

At the time of writing this report, NA does not take any anti-inflammatory drug, undergoes a remarkable improvement in her quality of life, keeping daily consumption for 15 consecutive months of 1 gram of SE, bone support supplementation of 500 mg Calcitriol (1,25-dihydroxycholecalciferol) every month, milk of magnesia and an annual dose of Zoledronic Acid.


CEREBROVASCULAR ACCIDENT (STROKE) - SE = Stem Enhance

In September 2008, GE, a 78 year old male surgical oncologist who was otherwise in good health, had a stroke. The MRI/MRA revealed an acute infarct involving the right lentiform nucleus, moderately extensive chronic small vessel ischemic changes, chronic lacunar infarct involving the right ventromedial thalamus, and intracranial atherosclerotic vascular disease.

The stroke left GE with aphasia and a reduced ability to perform any physical activity.

October 2009, 13 months after the stroke, GE began taking SE; GE consumed 1 gram twice Tissue Regeneration - From Basic Biology to Clinical Application 186 per day and after 8 weeks on the product GE noticed improvement with his speech and experienced more energy with improved balance.

In April 2010 a repeat MRI/MRA showed no evidence of an acute infarct. GE's aphasia was completely resolved at this point and his overall mobility was improved allowing him to perform all activities of daily living.

In January of 2011 a repeat MRI/MRA of the anterior and posterior cerebral arteries demonstrated no evidence of hemodynamically significant stenosis, and revealed normal vertebrobasilar arteries with no evidence of intracranial aneurysm or vascular malformation.

To date, GE has resumed playing tennis at age 81, walks around the mall in the neighbourhood with other senior citizens and has returned to his professional activity as a surgeon.




KIDNEY FAILURE - SE = Stem Enhance

The whole paragraph should read: "GW is 36 months old; he was born with a malfunctioning valve in the urethra, compromising the flow of urine at birth. At ten days old he had surgery to repair the urethra, however, the damage to the kidneys and the bladder were already evident, caused from the retention of urine at birth. Following the surgical procedure, scar tissue was observed to the wall of the bladder and one of the kidneys did not respond, eventually that kidney quit working and began to atrophy. A scar was also left on his hand caused from an IV being ripped out after surgery.

Before SE was introduced, GW had stopped growing at 15 months of age and multiple health issues were leading him toward a kidney transplant. Furthermore, GW had been on antibiotics for one year due to multiple infections. His body was not eliminating fluid as it should, as evidenced by the worsening of edema resulting in the use of diuretics. GW had purple feet caused from compromised circulation, dark spots were observed on his back, his eyes were blood shot and his overall presentation was pale in appearance. GW's activity was nothing normal for a one and a half year old child; his energy level was very depleted and he was unable to play like a normal toddler.

GW was 21 months old when SE was introduced at 250 mg per day. After 3 days on SE his mother reported that his eyes were crystal clear and he was observed running through the house full of energy. The dark spots on his back began to fade after one week of SE consumption. Red colour was seen on GW cheeks for the first time since he was born.

After 75 days on SE, GW had grown 6cm taller and the shrinking kidney at birth had measured 0.8cm larger. GW is off all pharmaceutical medications to date and his bladder and kidney are back to normal functioning to their fullest capacity, the scar to his hand is completely gone.


NOTE: All the above Testimonials were copied from the actual report from the Research that went into the creating of Stem Enhance.

Research Team consisted of... Christian Drapeau, George Eufemio, Paola Mazzoni, Gerhard D. Roth and Susan Strandberg.